Faiza C.
- Country
- France
- Department
- HEPATOGASTROENTEROLOGIE
Research Overview
- Efficacy of Ursodeoxycholic Acid versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy: A Multicenter, Controlled, Randomized, Open Trial
- Fecal microbiota transplantation for primary sclerosing cholangitis - randomized study versus sham transplantation (FMT-SCLER).
Data & Insights
Has run more than one trial at 2 of 15 partner sites.
Specializations
Hepatobiliary Oncology
Hepatocellular carcinoma, biliary tract cancer, and cholangiocarcinoma are central areas of interest, with attention to advanced and unresectable liver and biliary malignancies, including post-locoregional and adjuvant therapeutic settings.
- Advanced hepatocellular carcinoma
- Cholangiocarcinoma and biliary tract cancer
- Metabolic liver disease and cirrhosis-related cancer care
- Neuroendocrine and digestive tract tumors
The therapeutic focus includes liver cancer management, metastatic gastrointestinal malignancies, and treatment strategies relevant to hepatology-linked oncology.
Digestive Inflammatory Disease
Clinical activity also covers Crohn's disease, ulcerative colitis, irritable bowel syndrome, and eosinophilic esophagitis, reflecting a strong interest in immune-mediated disorders of the digestive system.
- Crohn's disease
- Ulcerative colitis
- Irritable bowel syndrome
- Eosinophilic gastrointestinal disease
Therapeutic involvement extends to microbiota-based therapy, biologic treatment, and symptom control in chronic gastrointestinal inflammation.
Autoimmune and Systemic Immune Disorders
Research interests include systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, systemic sclerosis, and vasculitis, with broader involvement in immune-mediated organ disease.
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Systemic sclerosis and interstitial lung disease
- ANCA-associated vasculitis
The therapeutic landscape includes autoimmune rheumatic disease, immune thrombocytopenia, and inflammatory myopathy care.
Hematologic Malignancies
There is substantial involvement in acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, and lymphoma, spanning both aggressive and relapsed hematologic cancers.
- Acute myeloid leukemia
- Acute lymphoblastic leukemia
- Myelodysplastic syndromes
- B-cell and T-cell lymphomas
Therapeutic interests include targeted therapy, immunotherapy, and transplant-related hematology.
Solid Tumors and Precision Oncology
Additional work spans non-small cell lung cancer, renal cell carcinoma, urothelial carcinoma, melanoma, and head and neck cancer, with emphasis on advanced and biomarker-defined disease.
- Non-small cell lung cancer
- Renal cell carcinoma
- Urothelial carcinoma
- Head and neck squamous cell carcinoma
These activities align with precision oncology, molecularly targeted treatment, and advanced solid tumor care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.